Skip to main content
Premium Trial:

Request an Annual Quote

Blue Heron Receives NIH Grant for Universal Restriction Enzyme System Project

NEW YORK, Sept. 13 (GenomeWeb News) - Blue Heron Biotechnology said last week that it has received a phase I small business innovative research grant from the National Institutes of Health to develop a universal restriction enzyme system.

 

The grant, worth $137,910, was awarded by the National Institute of General Medical Science and the National Human Genome Research Institute, said Blue Heron.

 

According to the company, the goal of the grant project is to develop "a uniform method for assembling large DNA molecules by ligation of sticky-ended fragments, regardless of the sequence, the fragment length, or the presence of restriction sites." This method, Blue Heron said, is expected to allow the use of restriction digestion to release any cloned fragment and allow complete control of the sticky ends on these fragments.

 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.